Guerra, Luca http://orcid.org/0000-0003-4197-2060
Chauvie, Stephane
Fallanca, Federico
Bergesio, Fabrizio
Marcheselli, Luigi
Durmo, Rexhep
Peano, Simona
Franceschetto, Antonella
Monaco, Lavinia
Barbieri, Emiliano
Ladetto, Marco
Musuraca, Gerardo
Tosi, Patrizia
Bianchi, Benedetta
Bolis, Silvia Anna Maria
Pavone, Vincenzo
Chiarenza, Annalisa
Arcari, Annalisa
Califano, Catello
Bari, Alessia
Massaia, Massimo
Conconi, Annarita
Musto, Pellegrino
Mannina, Donato
Roti, Giovanni
Galimberti, Sara
Gini, Guido
Falcinelli, Flavio
Vitolo, Umberto
Usai, Sara Veronica
Stefani, Piero Maria
Ibatici, Adalberto
Liberati, Anna Marina
Pennese, Elsa
Perrone, Tommasina
Versari, Annibale
Luminari, Stefano
,
Funding for this research was provided by:
Associazione Angela Serra per la Ricerca sul Cancro
Ministero della Salute (Bando Progetti di Ricerca Giovani Ricercatori-Ricerca Finalizzata 2011-2012)
Article History
Received: 27 December 2023
Accepted: 12 May 2024
First Online: 25 May 2024
Declarations
:
: The authors have no conflicts of interest to disclose related to the subjects, matter or materials discussed in this manuscript.
: The FOLL12 trial (NCT02063685; ) is a multicentric clinical trial and it was approved by the institutional review boards at each participating centre. This study involved humans and was conducted according to the Declaration of Helsinki and Good Clinical Practice guidelines.
: Informed consent was obtained from all individual participants before the enrolment in the study.
: Not applicable: the paper does not contain individual person’s data in any form.